Triple
T14008610
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Sinovac |
E337018
|
entity |
| Predicate | legalName |
P66
|
FINISHED |
| Object | Sinovac Biotech Ltd. |
E337018
|
NE FINISHED |
Disambiguation candidates (1 decision)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Sinovac Biotech Ltd. Context triple: [Sinovac, legalName, Sinovac Biotech Ltd.]
-
A.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
B.
Sinovac
chosen
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
C.
Fosun Pharma
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
D.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
E.
Sinobo Group
Sinobo Group is a Chinese investment and real estate conglomerate best known in sports for its ownership stake in Beijing Guoan Football Club.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d81c645c5c8190b1fd16a285a1b78a |
elicitation | completed |
| NER | batch_69de2ed44f90819099ad08c09c066b56 |
ner | completed |
| NED1 | batch_69fbaca5fb48819090fff1fd22e8a15c |
ned_source_triple | completed |
Created at: April 9, 2026, 10:19 p.m.